J. Goldman & CO LP Bio Xcel Therapeutics, Inc. Transaction History

J. Goldman & CO LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$39.04 - $64.6 $987,829 - $1.63 Million	-25,303 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$42.46 - $56.58 $742,837 - $989,867	-17,495 Reduced 40.88%	25,303 $1.17 Million
Q3 2020 Nov 16, 2020	BUY	$37.44 - $64.63 $1.6 Million - $2.77 Million	42,798 New	42,798 $1.86 Million

3.11M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $9.25M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.